NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
7.18
-0.08 (-1.17%)
Jul 14, 2025, 4:00 PM - Market closed

NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $923.38 million as of July 14, 2025. Its market cap has decreased by -44.72% in one year.

Market Cap
923.38M
Enterprise Value
1.18B
1-Year Change
-44.72%
Ranking
Category
Stock Price
$7.18

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $923.38M, an increase of 11,588.39%. That is a compound annual growth rate of 25.00%.

History

DateMarket Cap% Change
Jul 11, 2025 934.30M -55.83%
Dec 31, 2024 2.12B 2.57%
Dec 29, 2023 2.06B 76.73%
Dec 30, 2022 1.17B -72.22%
Dec 31, 2021 4.20B -29.72%
Dec 31, 2020 5.98B 95.74%
Dec 31, 2019 3.05B 160.37%
Dec 31, 2018 1.17B 64.64%
Dec 29, 2017 712.40M 5.87%
Dec 30, 2016 672.90M 41.66%
Dec 31, 2015 475.00M 89.92%
Dec 31, 2014 250.10M 41.06%
Dec 31, 2013 177.30M 57.88%
Dec 31, 2012 112.30M 85.62%
Dec 30, 2011 60.50M 24.49%
Dec 31, 2010 48.60M -12.90%
Dec 31, 2009 55.80M 189.12%
Dec 31, 2008 19.30M -43.07%
Dec 31, 2007 33.90M -16.30%
Dec 29, 2006 40.50M 841.86%
Dec 30, 2005 4.30M -20.37%
Dec 31, 2004 5.40M -31.65%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 711.91B
Johnson & Johnson 377.51B
AbbVie 339.94B
Novo Nordisk 305.41B
UnitedHealth Group 275.86B
Novartis AG 236.71B
Abbott Laboratories 229.69B
AstraZeneca 218.74B
Market Cap Rankings